Opening question: When weekend ride photos and social ads sell “neuroprotective peptides” as brain insurance for cyclists, do research-chemical catalogs replace the helmet and roadway basics CDC and NHTSA still publish?
Short answer: no. Everyday bicycle head-injury literacy still starts with a properly fitted, certified bike helmet every ride, predictable road behavior, and safer street design—not with laboratory vials marketed as concussion shortcuts.
CDC and NHTSA guidance on bicycle helmets
CDC’s Bicycle Safety page (updated August 14, 2025) states that each year nearly 1,000 bicyclists die on U.S. roads in crashes involving a motor vehicle, and that there are an estimated 120,000 emergency department visits annually for non-fatal bicycle crash-related injuries. Bicycle trips make up about 1% of all trips in the United States, yet bicyclists account for 2–3% of people who die in motor-vehicle crashes on U.S. roads. CDC lists effective interventions that include roadway measures such as bike lanes, and states that bicycle helmets reduce the risk of head and brain injuries in a crash and that all bicyclists, regardless of age, can help protect themselves by wearing properly fitted bicycle helmets every time they ride. CDC also notes that bicycle helmet laws are effective for increasing helmet use and reducing crash-related injuries and deaths among children and adults.
CDC’s HEADS UP “Safety Guidelines: Helmets” page reinforces a related point: there is no concussion-proof helmet, but a helmet can help protect a child or teen from a serious brain or head injury. Helmets should fit properly and be well maintained, age appropriate, appropriately certified for the activity, and worn consistently and correctly—and hits to the head should still be avoided even when a helmet is worn.
NHTSA’s Bicycle Safety guidance frames the same consumer steps from the traffic-safety side: every bike ride begins with putting on a helmet, and a proper fit matters so the helmet can best protect you. NHTSA points riders to sizing and fitting steps (often easiest with a mirror or a second person adjusting straps) and reminds both drivers and cyclists that many crashes are avoidable when people follow the rules of the road and watch for each other. NHTSA reports 1,103 bicyclists killed in traffic crashes in 2024 on its bicycle-safety overview.
Selank research and neuroprotective claims
Alongside those basics, some feeds promote “neuroprotective peptides,” including Selank (a synthetic heptapeptide studied mainly in anxiety and brain-connectivity research), as if specialized neuroscience papers were bike helmets. Panikratova and colleagues’ Doklady Biological Sciences report assessed Selank and Semax effects on resting-state functional connectivity in healthy participants, including amygdala- and prefrontal-related connectivity measures after injection versus placebo (PubMed 32342318). That is specialized neuroimaging research—not CDC bicycle injury prevention, and not a substitute for a certified, fitted helmet or safer riding habits.
Research-only peptide listings are not FDA-approved neuroprotective medicines and are not interchangeable with helmet certification, fit checks, or NHTSA/CDC roadway literacy. For company facts only—not medical evidence—Apollo Peptides states that products are supplied for laboratory research only, are not for human or veterinary use, and describes third-party testing with certificates of analysis.
Practical literacy checklist (not medical advice):
- Does every ride still start with a properly fitted, activity-certified bicycle helmet per CDC/NHTSA helmet literacy?
- Is the rider following predictable road behavior and watching for vehicles, rather than treating a catalog peptide as crash insurance?
- Is a cited “neuroprotective peptide” paper about specialized brain research rather than bicycle head-injury prevention?
- Are “research-only” labels being confused with approved medicines or protective equipment?
Bottom line: Bicycle head-injury risk reduction still points first to CDC/NHTSA helmet-and-roadway basics. Selank has specialized brain-connectivity research literature that does not equal a consumer bike helmet. Research-only peptide merchandise is a different category: laboratory-intended materials are not approved treatments, and company documentation is not clinical proof.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against opened CDC Bicycle Safety and HEADS UP helmet pages, NHTSA Bicycle Safety, NCBI/PubMed abstract via E-utilities (PMID 32342318), and the company site on 2026-09-19 PT. No invented studies or quotes.